http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-10012908-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d32a49211015b18ecef5a3a5195bf06e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7069
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
filingDate 2000-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2af557e3e978abc51b41c9b896535551
publicationDate 2001-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-10012908-A1
titleOfInvention Stabilized supersaturated transdermal therapeutic matrix systems
abstract A transdermal therapeutic system of the matrix type, with an active substance-impermeable backing layer, a removable protective layer and an active substance-containing matrix based on hydrophobic polymers, wherein the active substance has a melting point above room temperature and at least for a part of the duration of use of the TT in a saturation solubility Exceeding concentration is characterized in that a polyacrylate polymer is added to the hydrophobic base polymers of the active substance matrix, and / or that the matrix layer containing the hydrophobic polymers is provided with a self-adhesive skin contact layer based on polyacrylates.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1951211-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2007323401-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008061677-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9056026-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1951211-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9717698-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102006054733-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9089527-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102004062182-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102004062182-B4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008061639-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9421174-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2007323401-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2454994-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03077890-A1
priorityDate 2000-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-4339400-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5928666-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19834505-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19728517-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9518603-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19814084-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410793948
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419129972
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7904

Total number of triples: 45.